nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0953	0.113	CbGbCtD
Ranitidine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0819	0.0971	CbGbCtD
Ranitidine—SLC22A8—Methotrexate—ankylosing spondylitis	0.0802	0.0951	CbGbCtD
Ranitidine—CYP2C19—Prednisone—ankylosing spondylitis	0.0615	0.0729	CbGbCtD
Ranitidine—ABCB1—Betamethasone—ankylosing spondylitis	0.0532	0.0631	CbGbCtD
Ranitidine—ABCB1—Prednisolone—ankylosing spondylitis	0.0525	0.0623	CbGbCtD
Ranitidine—ABCB1—Prednisone—ankylosing spondylitis	0.0496	0.0588	CbGbCtD
Ranitidine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.049	0.0582	CbGbCtD
Ranitidine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0476	0.0564	CbGbCtD
Ranitidine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0384	0.0455	CbGbCtD
Ranitidine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0372	0.0441	CbGbCtD
Ranitidine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0319	0.0378	CbGbCtD
Ranitidine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0315	0.0373	CbGbCtD
Ranitidine—ABCB1—Dexamethasone—ankylosing spondylitis	0.031	0.0367	CbGbCtD
Ranitidine—CYP3A4—Prednisone—ankylosing spondylitis	0.0297	0.0353	CbGbCtD
Ranitidine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0292	0.0346	CbGbCtD
Ranitidine—ABCB1—Methotrexate—ankylosing spondylitis	0.0249	0.0295	CbGbCtD
Ranitidine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0186	0.022	CbGbCtD
Ranitidine—Dermatitis contact—Betamethasone—ankylosing spondylitis	0.0011	0.00699	CcSEcCtD
Ranitidine—Vasculitis—Prednisone—ankylosing spondylitis	0.000992	0.00631	CcSEcCtD
Ranitidine—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.000919	0.00585	CcSEcCtD
Ranitidine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.000846	0.00538	CcSEcCtD
Ranitidine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.000844	0.00537	CcSEcCtD
Ranitidine—Vasculitis—Methotrexate—ankylosing spondylitis	0.000829	0.00528	CcSEcCtD
Ranitidine—Pancreatitis—Prednisolone—ankylosing spondylitis	0.000819	0.00522	CcSEcCtD
Ranitidine—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.000802	0.0051	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000783	0.00498	CcSEcCtD
Ranitidine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000767	0.00488	CcSEcCtD
Ranitidine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000767	0.00488	CcSEcCtD
Ranitidine—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.00076	0.00483	CcSEcCtD
Ranitidine—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.000754	0.0048	CcSEcCtD
Ranitidine—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000754	0.0048	CcSEcCtD
Ranitidine—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.000752	0.00479	CcSEcCtD
Ranitidine—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.000724	0.00461	CcSEcCtD
Ranitidine—Bradycardia—Prednisolone—ankylosing spondylitis	0.000681	0.00433	CcSEcCtD
Ranitidine—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000669	0.00426	CcSEcCtD
Ranitidine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000668	0.00425	CcSEcCtD
Ranitidine—Sweating—Methylprednisolone—ankylosing spondylitis	0.000655	0.00417	CcSEcCtD
Ranitidine—Hepatic failure—Methotrexate—ankylosing spondylitis	0.000653	0.00416	CcSEcCtD
Ranitidine—Weight decreased—Dexamethasone—ankylosing spondylitis	0.000631	0.00402	CcSEcCtD
Ranitidine—Weight decreased—Betamethasone—ankylosing spondylitis	0.000631	0.00402	CcSEcCtD
Ranitidine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000626	0.00399	CcSEcCtD
Ranitidine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000625	0.00398	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00062	0.00394	CcSEcCtD
Ranitidine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000611	0.00389	CcSEcCtD
Ranitidine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000598	0.0038	CcSEcCtD
Ranitidine—Pancreatitis—Prednisone—ankylosing spondylitis	0.000595	0.00379	CcSEcCtD
Ranitidine—Erythema—Prednisolone—ankylosing spondylitis	0.000582	0.00371	CcSEcCtD
Ranitidine—Bradycardia—Betamethasone—ankylosing spondylitis	0.000568	0.00362	CcSEcCtD
Ranitidine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000568	0.00362	CcSEcCtD
Ranitidine—Neutropenia—Prednisone—ankylosing spondylitis	0.000568	0.00361	CcSEcCtD
Ranitidine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000559	0.00356	CcSEcCtD
Ranitidine—Hallucination—Betamethasone—ankylosing spondylitis	0.000555	0.00354	CcSEcCtD
Ranitidine—Hallucination—Dexamethasone—ankylosing spondylitis	0.000555	0.00354	CcSEcCtD
Ranitidine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00055	0.0035	CcSEcCtD
Ranitidine—Weight decreased—Prednisone—ankylosing spondylitis	0.000549	0.0035	CcSEcCtD
Ranitidine—Vision blurred—Prednisolone—ankylosing spondylitis	0.000549	0.00349	CcSEcCtD
Ranitidine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000548	0.00349	CcSEcCtD
Ranitidine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00054	0.00344	CcSEcCtD
Ranitidine—Erythema—Triamcinolone—ankylosing spondylitis	0.000536	0.00341	CcSEcCtD
Ranitidine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000534	0.0034	CcSEcCtD
Ranitidine—Angioedema—Prednisolone—ankylosing spondylitis	0.000532	0.00339	CcSEcCtD
Ranitidine—Breast disorder—Methotrexate—ankylosing spondylitis	0.000531	0.00338	CcSEcCtD
Ranitidine—Malaise—Prednisolone—ankylosing spondylitis	0.000525	0.00334	CcSEcCtD
Ranitidine—Vertigo—Prednisolone—ankylosing spondylitis	0.000523	0.00333	CcSEcCtD
Ranitidine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000503	0.0032	CcSEcCtD
Ranitidine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000499	0.00317	CcSEcCtD
Ranitidine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000499	0.00317	CcSEcCtD
Ranitidine—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000498	0.00317	CcSEcCtD
Ranitidine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000497	0.00316	CcSEcCtD
Ranitidine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000496	0.00316	CcSEcCtD
Ranitidine—Bradycardia—Prednisone—ankylosing spondylitis	0.000495	0.00315	CcSEcCtD
Ranitidine—Alopecia—Betamethasone—ankylosing spondylitis	0.000493	0.00314	CcSEcCtD
Ranitidine—Alopecia—Dexamethasone—ankylosing spondylitis	0.000493	0.00314	CcSEcCtD
Ranitidine—Discomfort—Prednisolone—ankylosing spondylitis	0.00049	0.00312	CcSEcCtD
Ranitidine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000489	0.00311	CcSEcCtD
Ranitidine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000488	0.00311	CcSEcCtD
Ranitidine—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000487	0.0031	CcSEcCtD
Ranitidine—Erythema—Dexamethasone—ankylosing spondylitis	0.000486	0.00309	CcSEcCtD
Ranitidine—Erythema—Betamethasone—ankylosing spondylitis	0.000486	0.00309	CcSEcCtD
Ranitidine—Hallucination—Prednisone—ankylosing spondylitis	0.000484	0.00308	CcSEcCtD
Ranitidine—Malaise—Triamcinolone—ankylosing spondylitis	0.000483	0.00307	CcSEcCtD
Ranitidine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000482	0.00307	CcSEcCtD
Ranitidine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000482	0.00307	CcSEcCtD
Ranitidine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000481	0.00306	CcSEcCtD
Ranitidine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00048	0.00306	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000475	0.00303	CcSEcCtD
Ranitidine—Neutropenia—Methotrexate—ankylosing spondylitis	0.000475	0.00302	CcSEcCtD
Ranitidine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000467	0.00298	CcSEcCtD
Ranitidine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000464	0.00295	CcSEcCtD
Ranitidine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000463	0.00295	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000459	0.00292	CcSEcCtD
Ranitidine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000456	0.0029	CcSEcCtD
Ranitidine—Pneumonia—Methotrexate—ankylosing spondylitis	0.000455	0.0029	CcSEcCtD
Ranitidine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000455	0.0029	CcSEcCtD
Ranitidine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000455	0.0029	CcSEcCtD
Ranitidine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000451	0.00287	CcSEcCtD
Ranitidine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000451	0.00287	CcSEcCtD
Ranitidine—Discomfort—Triamcinolone—ankylosing spondylitis	0.00045	0.00287	CcSEcCtD
Ranitidine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000449	0.00286	CcSEcCtD
Ranitidine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000444	0.00283	CcSEcCtD
Ranitidine—Angioedema—Betamethasone—ankylosing spondylitis	0.000444	0.00283	CcSEcCtD
Ranitidine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00044	0.0028	CcSEcCtD
Ranitidine—Malaise—Dexamethasone—ankylosing spondylitis	0.000438	0.00279	CcSEcCtD
Ranitidine—Malaise—Betamethasone—ankylosing spondylitis	0.000438	0.00279	CcSEcCtD
Ranitidine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000437	0.00278	CcSEcCtD
Ranitidine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000437	0.00278	CcSEcCtD
Ranitidine—Vertigo—Betamethasone—ankylosing spondylitis	0.000437	0.00278	CcSEcCtD
Ranitidine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000436	0.00278	CcSEcCtD
Ranitidine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000434	0.00276	CcSEcCtD
Ranitidine—Sweating—Methotrexate—ankylosing spondylitis	0.000434	0.00276	CcSEcCtD
Ranitidine—Insomnia—Prednisolone—ankylosing spondylitis	0.00043	0.00274	CcSEcCtD
Ranitidine—Alopecia—Prednisone—ankylosing spondylitis	0.00043	0.00273	CcSEcCtD
Ranitidine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000427	0.00272	CcSEcCtD
Ranitidine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000426	0.00271	CcSEcCtD
Ranitidine—Erythema—Prednisone—ankylosing spondylitis	0.000423	0.00269	CcSEcCtD
Ranitidine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000423	0.00269	CcSEcCtD
Ranitidine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000422	0.00269	CcSEcCtD
Ranitidine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000422	0.00268	CcSEcCtD
Ranitidine—Myalgia—Betamethasone—ankylosing spondylitis	0.000414	0.00263	CcSEcCtD
Ranitidine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000414	0.00263	CcSEcCtD
Ranitidine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000409	0.0026	CcSEcCtD
Ranitidine—Discomfort—Betamethasone—ankylosing spondylitis	0.000409	0.0026	CcSEcCtD
Ranitidine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000407	0.00259	CcSEcCtD
Ranitidine—Pain—Prednisolone—ankylosing spondylitis	0.000406	0.00259	CcSEcCtD
Ranitidine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000406	0.00259	CcSEcCtD
Ranitidine—Vision blurred—Prednisone—ankylosing spondylitis	0.000399	0.00254	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000398	0.00253	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000397	0.00253	CcSEcCtD
Ranitidine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000397	0.00252	CcSEcCtD
Ranitidine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000397	0.00252	CcSEcCtD
Ranitidine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000395	0.00252	CcSEcCtD
Ranitidine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000394	0.00251	CcSEcCtD
Ranitidine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000393	0.0025	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000392	0.00249	CcSEcCtD
Ranitidine—Anaemia—Prednisone—ankylosing spondylitis	0.000391	0.00249	CcSEcCtD
Ranitidine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00039	0.00248	CcSEcCtD
Ranitidine—Agitation—Prednisone—ankylosing spondylitis	0.000389	0.00248	CcSEcCtD
Ranitidine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000388	0.00247	CcSEcCtD
Ranitidine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000388	0.00247	CcSEcCtD
Ranitidine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000387	0.00246	CcSEcCtD
Ranitidine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000387	0.00246	CcSEcCtD
Ranitidine—Angioedema—Prednisone—ankylosing spondylitis	0.000387	0.00246	CcSEcCtD
Ranitidine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000384	0.00245	CcSEcCtD
Ranitidine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000383	0.00244	CcSEcCtD
Ranitidine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000383	0.00244	CcSEcCtD
Ranitidine—Malaise—Prednisone—ankylosing spondylitis	0.000382	0.00243	CcSEcCtD
Ranitidine—Vertigo—Prednisone—ankylosing spondylitis	0.00038	0.00242	CcSEcCtD
Ranitidine—Urticaria—Prednisolone—ankylosing spondylitis	0.000378	0.0024	CcSEcCtD
Ranitidine—Pain—Triamcinolone—ankylosing spondylitis	0.000374	0.00238	CcSEcCtD
Ranitidine—Hypotension—Betamethasone—ankylosing spondylitis	0.000371	0.00236	CcSEcCtD
Ranitidine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000371	0.00236	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000361	0.0023	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000361	0.0023	CcSEcCtD
Ranitidine—Myalgia—Prednisone—ankylosing spondylitis	0.00036	0.00229	CcSEcCtD
Ranitidine—Arthralgia—Prednisone—ankylosing spondylitis	0.00036	0.00229	CcSEcCtD
Ranitidine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00036	0.00229	CcSEcCtD
Ranitidine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000359	0.00229	CcSEcCtD
Ranitidine—Alopecia—Methotrexate—ankylosing spondylitis	0.000359	0.00229	CcSEcCtD
Ranitidine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000359	0.00228	CcSEcCtD
Ranitidine—Insomnia—Betamethasone—ankylosing spondylitis	0.000359	0.00228	CcSEcCtD
Ranitidine—Discomfort—Prednisone—ankylosing spondylitis	0.000356	0.00227	CcSEcCtD
Ranitidine—Erythema—Methotrexate—ankylosing spondylitis	0.000354	0.00225	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00035	0.00223	CcSEcCtD
Ranitidine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000347	0.00221	CcSEcCtD
Ranitidine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000346	0.00221	CcSEcCtD
Ranitidine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000345	0.0022	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000345	0.0022	CcSEcCtD
Ranitidine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000345	0.00219	CcSEcCtD
Ranitidine—Pain—Betamethasone—ankylosing spondylitis	0.000339	0.00216	CcSEcCtD
Ranitidine—Pain—Dexamethasone—ankylosing spondylitis	0.000339	0.00216	CcSEcCtD
Ranitidine—Tachycardia—Prednisone—ankylosing spondylitis	0.000337	0.00215	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000334	0.00213	CcSEcCtD
Ranitidine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000333	0.00212	CcSEcCtD
Ranitidine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000328	0.00209	CcSEcCtD
Ranitidine—Anaemia—Methotrexate—ankylosing spondylitis	0.000327	0.00208	CcSEcCtD
Ranitidine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000327	0.00208	CcSEcCtD
Ranitidine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000327	0.00208	CcSEcCtD
Ranitidine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000322	0.00205	CcSEcCtD
Ranitidine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000321	0.00205	CcSEcCtD
Ranitidine—Malaise—Methotrexate—ankylosing spondylitis	0.000319	0.00203	CcSEcCtD
Ranitidine—Vertigo—Methotrexate—ankylosing spondylitis	0.000318	0.00202	CcSEcCtD
Ranitidine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000317	0.00202	CcSEcCtD
Ranitidine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000315	0.00201	CcSEcCtD
Ranitidine—Urticaria—Betamethasone—ankylosing spondylitis	0.000315	0.00201	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000315	0.002	CcSEcCtD
Ranitidine—Dizziness—Prednisolone—ankylosing spondylitis	0.000314	0.002	CcSEcCtD
Ranitidine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000313	0.002	CcSEcCtD
Ranitidine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000313	0.002	CcSEcCtD
Ranitidine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000313	0.002	CcSEcCtD
Ranitidine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000313	0.002	CcSEcCtD
Ranitidine—Insomnia—Prednisone—ankylosing spondylitis	0.000312	0.00199	CcSEcCtD
Ranitidine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000309	0.00197	CcSEcCtD
Ranitidine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000309	0.00196	CcSEcCtD
Ranitidine—Myalgia—Methotrexate—ankylosing spondylitis	0.000301	0.00192	CcSEcCtD
Ranitidine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000301	0.00192	CcSEcCtD
Ranitidine—Chest pain—Methotrexate—ankylosing spondylitis	0.000301	0.00192	CcSEcCtD
Ranitidine—Rash—Prednisolone—ankylosing spondylitis	0.0003	0.00191	CcSEcCtD
Ranitidine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000299	0.00191	CcSEcCtD
Ranitidine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000298	0.0019	CcSEcCtD
Ranitidine—Headache—Prednisolone—ankylosing spondylitis	0.000298	0.0019	CcSEcCtD
Ranitidine—Discomfort—Methotrexate—ankylosing spondylitis	0.000297	0.00189	CcSEcCtD
Ranitidine—Constipation—Prednisone—ankylosing spondylitis	0.000295	0.00188	CcSEcCtD
Ranitidine—Confusional state—Methotrexate—ankylosing spondylitis	0.000291	0.00185	CcSEcCtD
Ranitidine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000289	0.00184	CcSEcCtD
Ranitidine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000289	0.00184	CcSEcCtD
Ranitidine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000288	0.00184	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000285	0.00181	CcSEcCtD
Ranitidine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000283	0.0018	CcSEcCtD
Ranitidine—Nausea—Prednisolone—ankylosing spondylitis	0.000282	0.0018	CcSEcCtD
Ranitidine—Pruritus—Betamethasone—ankylosing spondylitis	0.000281	0.00179	CcSEcCtD
Ranitidine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000281	0.00179	CcSEcCtD
Ranitidine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000279	0.00178	CcSEcCtD
Ranitidine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000278	0.00177	CcSEcCtD
Ranitidine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000277	0.00176	CcSEcCtD
Ranitidine—Rash—Triamcinolone—ankylosing spondylitis	0.000276	0.00175	CcSEcCtD
Ranitidine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000275	0.00175	CcSEcCtD
Ranitidine—Rash—Methylprednisolone—ankylosing spondylitis	0.000275	0.00175	CcSEcCtD
Ranitidine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000275	0.00175	CcSEcCtD
Ranitidine—Urticaria—Prednisone—ankylosing spondylitis	0.000274	0.00175	CcSEcCtD
Ranitidine—Headache—Triamcinolone—ankylosing spondylitis	0.000274	0.00174	CcSEcCtD
Ranitidine—Headache—Methylprednisolone—ankylosing spondylitis	0.000273	0.00174	CcSEcCtD
Ranitidine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000273	0.00174	CcSEcCtD
Ranitidine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000273	0.00174	CcSEcCtD
Ranitidine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000271	0.00173	CcSEcCtD
Ranitidine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000271	0.00173	CcSEcCtD
Ranitidine—Hypotension—Methotrexate—ankylosing spondylitis	0.00027	0.00172	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000263	0.00167	CcSEcCtD
Ranitidine—Dizziness—Betamethasone—ankylosing spondylitis	0.000262	0.00167	CcSEcCtD
Ranitidine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000262	0.00167	CcSEcCtD
Ranitidine—Insomnia—Methotrexate—ankylosing spondylitis	0.000261	0.00166	CcSEcCtD
Ranitidine—Nausea—Triamcinolone—ankylosing spondylitis	0.00026	0.00165	CcSEcCtD
Ranitidine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000259	0.00165	CcSEcCtD
Ranitidine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000257	0.00164	CcSEcCtD
Ranitidine—Somnolence—Methotrexate—ankylosing spondylitis	0.000257	0.00163	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000254	0.00162	CcSEcCtD
Ranitidine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000252	0.00161	CcSEcCtD
Ranitidine—Vomiting—Betamethasone—ankylosing spondylitis	0.000252	0.00161	CcSEcCtD
Ranitidine—Rash—Dexamethasone—ankylosing spondylitis	0.00025	0.00159	CcSEcCtD
Ranitidine—Rash—Betamethasone—ankylosing spondylitis	0.00025	0.00159	CcSEcCtD
Ranitidine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00025	0.00159	CcSEcCtD
Ranitidine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00025	0.00159	CcSEcCtD
Ranitidine—Headache—Betamethasone—ankylosing spondylitis	0.000248	0.00158	CcSEcCtD
Ranitidine—Headache—Dexamethasone—ankylosing spondylitis	0.000248	0.00158	CcSEcCtD
Ranitidine—Pain—Methotrexate—ankylosing spondylitis	0.000247	0.00157	CcSEcCtD
Ranitidine—Pruritus—Prednisone—ankylosing spondylitis	0.000244	0.00156	CcSEcCtD
Ranitidine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000238	0.00151	CcSEcCtD
Ranitidine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000236	0.0015	CcSEcCtD
Ranitidine—Nausea—Betamethasone—ankylosing spondylitis	0.000236	0.0015	CcSEcCtD
Ranitidine—Nausea—Dexamethasone—ankylosing spondylitis	0.000236	0.0015	CcSEcCtD
Ranitidine—Urticaria—Methotrexate—ankylosing spondylitis	0.000229	0.00146	CcSEcCtD
Ranitidine—Dizziness—Prednisone—ankylosing spondylitis	0.000228	0.00145	CcSEcCtD
Ranitidine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000228	0.00145	CcSEcCtD
Ranitidine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000228	0.00145	CcSEcCtD
Ranitidine—Vomiting—Prednisone—ankylosing spondylitis	0.00022	0.0014	CcSEcCtD
Ranitidine—Rash—Prednisone—ankylosing spondylitis	0.000218	0.00139	CcSEcCtD
Ranitidine—Dermatitis—Prednisone—ankylosing spondylitis	0.000218	0.00138	CcSEcCtD
Ranitidine—Headache—Prednisone—ankylosing spondylitis	0.000216	0.00138	CcSEcCtD
Ranitidine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000213	0.00135	CcSEcCtD
Ranitidine—Nausea—Prednisone—ankylosing spondylitis	0.000205	0.00131	CcSEcCtD
Ranitidine—Pruritus—Methotrexate—ankylosing spondylitis	0.000204	0.0013	CcSEcCtD
Ranitidine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000197	0.00126	CcSEcCtD
Ranitidine—Dizziness—Methotrexate—ankylosing spondylitis	0.000191	0.00121	CcSEcCtD
Ranitidine—Vomiting—Methotrexate—ankylosing spondylitis	0.000184	0.00117	CcSEcCtD
Ranitidine—Rash—Methotrexate—ankylosing spondylitis	0.000182	0.00116	CcSEcCtD
Ranitidine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000182	0.00116	CcSEcCtD
Ranitidine—Headache—Methotrexate—ankylosing spondylitis	0.000181	0.00115	CcSEcCtD
Ranitidine—Nausea—Methotrexate—ankylosing spondylitis	0.000171	0.00109	CcSEcCtD
